<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901394</url>
  </required_header>
  <id_info>
    <org_study_id>09-0074</org_study_id>
    <nct_id>NCT00901394</nct_id>
  </id_info>
  <brief_title>Influence of Preoperative Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia</brief_title>
  <acronym>Mini-VINO</acronym>
  <official_title>Influence of Preoperative Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Anesthesia Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to find out if giving intravenous B-vitamins before general
      anesthesia with nitrous oxide prevents the increase in homocysteine, a metabolite that has
      been linked to cardiovascular complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative plasma total homocysteine concentrations (tHcy)</measure>
    <time_frame>Immediately postoperatively and on postoperative day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of MTHFR 677C&gt;T genotype on tHcy increase</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">577</enrollment>
  <condition>Cardiovascular Abnormalities</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive IV B-vitamins (1mg vitamin B12 and 5 mg folic acid diluted in 250 ml normal saline infusion) plus 60% nitrous oxide anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive placebo (250 ml normal saline infusion) plus 60% nitrous oxide anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive placebo (250 ml normal saline infusion) but NO nitrous oxide (60% air and oxygen mix).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B-vitamins</intervention_name>
    <description>IV vitamin B12 (cyanocobalamin) 1 mg, single administration over 30 min.
IV folic acid, 5 mg, single administration over 30 min.
Both diluted in 250 ml normal saline.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrous oxide (NO)</intervention_name>
    <description>60% nitrous oxide anesthesia</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo: only 250 ml normal saline, no B-vitamins</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo nitrous oxide</intervention_name>
    <description>NO nitrous oxide (60% air and oxygen mix).</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients scheduled for elective surgery with expected duration &gt; 2 hours

          -  Healthy patients undergoing moderate surgery where the use of N2O is unproblematic

        Exclusion Criteria:

          -  Contraindication against N2O (pneumothorax, mechanical bowel obstruction, middle ear
             occlusion, laparoscopic surgery, raised intracranial pressure)

          -  Patients requiring supplemental oxygen

          -  Urgent or emergent surgery

          -  Patients with vitamin B12 or folate deficiency or megaloblastic anemia

          -  Patients with seizure disorder (epilepsy)

          -  Allergy or hypersensitivity against IV cobalamin or folate

          -  Patients with Leber's disease (hereditary optic nerve atrophy)

          -  Patients taking supplemental vitamin B12 or folate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Nagele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Nagele P, Zeugswetter B, Wiener C, Burger H, Hüpfl M, Mittlböck M, Födinger M. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology. 2008 Jul;109(1):36-43. doi: 10.1097/ALN.0b013e318178820b.</citation>
    <PMID>18580170</PMID>
  </reference>
  <reference>
    <citation>Nagele P, Zeugswetter B, Eberle C, Hüpfl M, Mittlböck M, Födinger M. A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia. Pharmacogenet Genomics. 2009 May;19(5):325-9. doi: 10.1097/FPC.0b013e328328d54c.</citation>
    <PMID>19339913</PMID>
  </reference>
  <reference>
    <citation>Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology. 2008 Oct;109(4):657-63. doi: 10.1097/ALN.0b013e31818629db.</citation>
    <PMID>18813045</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <lastchanged_date>May 30, 2012</lastchanged_date>
  <firstreceived_date>May 8, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nitrous oxide</keyword>
  <keyword>cobalamin</keyword>
  <keyword>homocysteine</keyword>
  <keyword>vitamin B12</keyword>
  <keyword>folate</keyword>
  <keyword>No specific diseases targeted</keyword>
  <keyword>Focus is on all patients receiving general anesthesia with nitrous oxide for elective surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
